Medications for Hiv Nonprogressors
37 results
Atripla access (efavirenz, emtricitabine, and tenofovir disoproxil fumarate)
(EFAVIRENZ, EMTRICITABINE, and TENOFOVIR DISOPROXIL FUMARATE)Gilead Sciences Inc
Usage: ATRIPLA™ is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 40 kg, either as a complete regimen or in combination with other antiretroviral agents.
Cabenuva (cabotegravir and rilpivirine)
(cabotegravir and rilpivirine)ViiV Healthcare Company
Usage: CABENUVA is indicated for the treatment of HIV-1 infection in adults and adolescents (ages 12 and older, weighing at least 35 kg) as a complete regimen to replace existing antiretroviral therapy in those who are virologically suppressed and have no history of treatment failure or resistance.
Complera access (emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate)
(EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, and TENOFOVIR DISOPROXIL FUMARATE)Gilead Sciences Inc
Usage: COMPLERA™ is indicated for the treatment of HIV-1 infection in adults and pediatric patients (≥35 kg), either as initial therapy for those with baseline HIV-1 RNA ≤100,000 copies/mL or to replace a stable regimen in patients who are virologically suppressed with no treatment failures.
Descovy (emtricitabine and tenofovir alafenamide)
(emtricitabine and tenofovir alafenamide)Gilead Sciences Inc
Usage: DESCOVY is indicated for the treatment of HIV-1 infection in adults and pediatric patients (≥35 kg with other antiretrovirals; 14-35 kg excluding protease inhibitors). It is also used for pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents (≥35 kg), excluding those at risk from receptive vaginal sex.
Emtricitabine and tenofovir disoproxil fumarate (emtricitabine and tenofovir disoproxil fumarate)
(Emtricitabine and tenofovir disoproxil fumarate)NorthStar RxLLC
Usage: Emtricitabine and tenofovir disoproxil fumarate are indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents for adults and children (≥17 kg). They are also used for HIV-1 pre-exposure prophylaxis (PrEP) in at-risk patients (≥35 kg) to reduce sexually acquired HIV-1 infection risk.
Emtricitabine and tenofovir disoproxil fumarate (emtricitabine and tenofovir disoproxil fumarate)
(Emtricitabine and tenofovir disoproxil fumarate)American Health Packaging
Usage: Emtricitabine and tenofovir disoproxil fumarate are indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents in adults and children over 17 kg, and for pre-exposure prophylaxis (PrEP) in at-risk adolescents and adults weighing at least 35 kg.
Emtricitabine and tenofovir disoproxil fumarate (emtricitabine and tenofovir disoproxil fumarate)
(EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE)DIRECT RX
Usage: Emtricitabine and tenofovir disoproxil fumarate tablets are indicated for the treatment of HIV-1 infection in conjunction with other antiretroviral agents, and for pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents, provided they weigh at least 35 kg and have a negative HIV-1 test prior to initiation.
Emtricitabine and tenofovir disoproxil fumarate (emtricitabine and tenofovir disoproxil fumarate)
(Emtricitabine and Tenofovir Disoproxil Fumarate)Amneal Pharmaceuticals NY LLC
Usage: Emtricitabine and tenofovir disoproxil fumarate tablets are indicated for the treatment of HIV-1 infection in adults and pediatric patients (≥17 kg) and for pre-exposure prophylaxis (PrEP) in at-risk adolescents and adults (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection.
Emtricitabine and tenofovir disoproxil fumarate (emtricitabine and tenofovir disoproxil fumarate)
(Emtricitabine and Tenofovir Disoproxil Fumarate)Amneal Pharmaceuticals NY LLC
Usage: Emtricitabine and tenofovir disoproxil fumarate are indicated for the treatment of HIV-1 infection in adults and pediatric patients (≥17 kg) and for pre-exposure prophylaxis (PrEP) in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection.
Emtricitabine and tenofovir disoproxil fumarate (emtricitabine and tenofovir disoproxil fumarate)
(Emtricitabine and tenofovir disoproxil fumarate)NuCare Pharmaceuticals,Inc.
Usage: Emtricitabine and tenofovir disoproxil fumarate are indicated for the treatment of HIV-1 infection in adults and pediatric patients (≥17 kg) and for pre-exposure prophylaxis (PrEP) in at-risk individuals (≥35 kg) to reduce the risk of sexually acquired HIV-1.